MX2014010926A - Composicion herbaria para el tratamiento de transtornos metabolicos. - Google Patents

Composicion herbaria para el tratamiento de transtornos metabolicos.

Info

Publication number
MX2014010926A
MX2014010926A MX2014010926A MX2014010926A MX2014010926A MX 2014010926 A MX2014010926 A MX 2014010926A MX 2014010926 A MX2014010926 A MX 2014010926A MX 2014010926 A MX2014010926 A MX 2014010926A MX 2014010926 A MX2014010926 A MX 2014010926A
Authority
MX
Mexico
Prior art keywords
relates
treatment
metabolic disorders
extract
herbal composition
Prior art date
Application number
MX2014010926A
Other languages
English (en)
Spanish (es)
Inventor
Somesh Sharma
Arvind Saklani
Parikshit Gaikwad
Aslam Burhan
Original Assignee
Piramal Entpr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piramal Entpr Ltd filed Critical Piramal Entpr Ltd
Publication of MX2014010926A publication Critical patent/MX2014010926A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
MX2014010926A 2012-03-13 2013-03-12 Composicion herbaria para el tratamiento de transtornos metabolicos. MX2014010926A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261610002P 2012-03-13 2012-03-13
PCT/IB2013/051925 WO2013136257A1 (en) 2012-03-13 2013-03-12 Herbal composition for the treatment of metabolic disorders

Publications (1)

Publication Number Publication Date
MX2014010926A true MX2014010926A (es) 2015-04-10

Family

ID=49160323

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014010926A MX2014010926A (es) 2012-03-13 2013-03-12 Composicion herbaria para el tratamiento de transtornos metabolicos.

Country Status (13)

Country Link
US (1) US20150050373A1 (enExample)
EP (1) EP2825183A4 (enExample)
JP (1) JP2015509976A (enExample)
KR (1) KR20140138275A (enExample)
CN (1) CN104203258A (enExample)
AU (1) AU2013233930A1 (enExample)
CA (1) CA2866260A1 (enExample)
IL (1) IL234616A0 (enExample)
IN (1) IN2014MN01933A (enExample)
MX (1) MX2014010926A (enExample)
NZ (1) NZ630125A (enExample)
RU (1) RU2014140852A (enExample)
WO (1) WO2013136257A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102393596B1 (ko) 2016-04-22 2022-05-04 리셉터 홀딩스, 인크. 속효성 식물-계 의약 화합물 및 영양 보충제
EA201892396A1 (ru) 2016-12-02 2019-04-30 Ресептор Лайф Сайенсиз, Инк. Быстродействующие растительные лекарственные соединения и биологически активные добавки
AR117118A1 (es) 2018-11-19 2021-07-14 Receptor Holdings Inc Aminoácidos grasos n-acilados para reducir la variabilidad de absorción en composiciones a base de cannabinoides
US20220214367A1 (en) * 2019-04-15 2022-07-07 Board Of Regents, The University Of Texas System Calibration methods and compositions for biomolecule analysis

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211944A (en) * 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
US6774141B1 (en) * 1992-03-31 2004-08-10 The United States Of America As Represented By The Secretary Of Health And Human Services Calanolide and related antiviral compounds, compositions, and uses thereof
PT935417E (pt) * 1996-10-16 2009-07-17 Napo Pharmaceuticals Inc Formulações entéricas de composições poliméricas antidiarreicas de proantocianidina
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
FR2794973B1 (fr) * 1999-06-18 2001-09-14 Mousny Brigitte Utilisation d'huile de plantes du genre calophyllum extraite a temperature ambiante dans des compositions cosmetiques, dietetiques et therapeutiques
JP2001192317A (ja) * 2000-01-06 2001-07-17 Shiseido Co Ltd マトリックスメタロプロテアーゼ阻害剤
JP2005272326A (ja) * 2004-03-23 2005-10-06 A Pharma Kindai Co Ltd 抗アレルギー剤、抗掻痒剤、及び抗菌剤
FR2886547B1 (fr) * 2005-06-02 2009-06-05 Boucher Claude Henri Marie Ghi Composition cosmetique, dietetique, pharmaceutique obtenue a partir d'huile non raffinee exempte d'acides gras trans, d'esters phorboliques, extraite sans solvant
EP2529626B1 (en) * 2006-05-01 2017-11-22 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing colon cancer
JP2008081440A (ja) * 2006-09-27 2008-04-10 Noevir Co Ltd アロマターゼ活性促進剤
MX2009006728A (es) * 2006-12-20 2009-09-09 Novartis Ag Heterociclos de 5 miembros 2-sustituidos como inhibidores de scd.
FR2915095B1 (fr) * 2007-04-17 2013-08-23 Diaye Yacine Isabelle Monique N Creme de soin
WO2010065528A2 (en) * 2008-12-02 2010-06-10 Kreations By Kristin, L.C. Gymnema-containing lip balm compositions and associated methods
US8821948B2 (en) * 2010-03-04 2014-09-02 Steva A. Komeh-Nkrumah Therapeutic, bio-affecting and body treating composition

Also Published As

Publication number Publication date
JP2015509976A (ja) 2015-04-02
IN2014MN01933A (enExample) 2015-07-10
US20150050373A1 (en) 2015-02-19
EP2825183A4 (en) 2015-09-23
EP2825183A1 (en) 2015-01-21
KR20140138275A (ko) 2014-12-03
CN104203258A (zh) 2014-12-10
RU2014140852A (ru) 2016-05-10
NZ630125A (en) 2017-01-27
AU2013233930A1 (en) 2014-09-25
CA2866260A1 (en) 2013-09-19
WO2013136257A1 (en) 2013-09-19
IL234616A0 (en) 2014-11-30

Similar Documents

Publication Publication Date Title
MX2014012742A (es) Composicion para el tratamiento de transtornos metabólicos.
MX2019005379A (es) Derivado de pirazolo-heteroarilo, metodo de preparacion y uso medico del mismo.
CL2015003801A1 (es) Formulaciones de anticuerpos y metodos
UY33980A (es) Composición plaguicida, solución para la regulación del crecimiento de plantas y método para mejoraro regular el crecimiento de plantas.
NZ731248A (en) Cannabis extracts and methods of preparing and using same
CO2018001375A2 (es) Composiciones de retinoides tópicos
EA201500582A1 (ru) Тройные фунгицидные смеси
BR112015021888A8 (pt) inibidores de dna-pk, seus usos e composição farmacêutica
PE20181850A1 (es) Composiciones basadas en chlorelia seca y metodos para el mejoramiento de las plantas
CL2015001772A1 (es) Composición farmacéutica para el tratamiento de dolor cabeza, y método de preparación de la misma.
MX2016014854A (es) Compuestos y composiciones para inducir condrogenesis.
CO2018005971A2 (es) Composición de regulador de crecimiento vegetal que tiene efecto sinérgico
MX2015011316A (es) Imidazopiridazinas sustituidas.
MX2017004998A (es) Composicion que contiene un extracto o fraccion de una planta del genero justicia.
DOP2016000007A (es) Pirazolpiridinas sustituidas
UY36405A (es) Formulaciones reguladoras/bioestimulantes del crecimiento de las plantas y de los cultivos y métodos para usarlas
MX2016002890A (es) Metodos y composiciones para provocar resistencia a las enfermedades por hongos en productos de agricultura.
AR090790A1 (es) Mezcla para mejora del crecimiento de las plantas
CL2012002893A1 (es) Composición de al menos un ingrediente activo de origen vegetal o sintético análogo del mismo, o extracto de origen vegetal que lo contiene, en una solución acuosa, que además comprende lecitina como agente encapsulante; medicamento que la comprende; método para su preparación; y su uso para tratar parasitosis intestinales.
MX2014010926A (es) Composicion herbaria para el tratamiento de transtornos metabolicos.
MX2022014763A (es) Composiciones de grapiprant y metodos para usar las mismas.
MX373305B (es) Método para estabilizar una composición que contiene al menos un producto de deshidratación interna de un azúcar hidrogenado, composición resultante y usos de esta.
MX2015007991A (es) Composicion que comprende raphanus, theobroma y passiflora para el tratamiento del abuso de opiaceos y alcohol.
MX2015008538A (es) Composicion que comprende un extracto purificado que se aisla de pseudolysimachion rotundum var. subintegrum que contiene una cantidad abundante de ingrediente activo o los compuestos aislados del mismo, como un ingrediente activo para prevenir o tratar enfermedad pulmonar obstructiva cronica y su uso.
GT201300181A (es) Regulador del crecimiento de plantas y metodo para utilizar el mismo